CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.90 -0.01 (-1.33%)
As of: Oct 22, 2026 · 3:28 PM EDT

CytoMed Therapeutics (GDTC) Receivables - Net (2021 - 2026)

Updated

CytoMed Therapeutics' Receivables - Net came in at $1.78 million for Q2 2026, up 44.7% from $1.23 million a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Receivables - Net (2021 - 2026) Analysis & Trends

At the end of FY2025, CytoMed Therapeutics' Receivables - Net was $1.2 million, up 55.5% from FY2024.

  • Receivables - Net carries a four-year compound annual growth rate of 20.3% (FY2021 to FY2025).
  • Going back by year, Receivables - Net was $771,319 in FY2024 (-7.6%), $834,961 in FY2023 (+22.4%), $681,994 in FY2022 (+19.1%) and $572,462 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,167.71 Bn 1,136.29 Bn 19.71 Bn
2 Johnson & Johnson 647.75 Bn 567.61 Bn 17.30 Bn
3 AbbVie 503.60 Bn 476.71 Bn 12.70 Bn
4 Merck 368.10 Bn 322.48 Bn 12.21 Bn
5 Novartis Ag 303.19 Bn 267.18 Bn 11.24 Bn
6 Astrazeneca 268.04 Bn 241.73 Bn 12.86 Bn
7 Amgen 242.69 Bn 198.09 Bn 7.24 Bn
8 Gilead Sciences 194.89 Bn 169.09 Bn 6.22 Bn
9 Pfizer 173.31 Bn 119.95 Bn 10.94 Bn
10 CytoMed Therapeutics 10.46 Mn 855,548.76 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.78 Mn
Dec 31, 2025 1.22 Mn
Jun 30, 2025 1.23 Mn
Dec 31, 2024 758,006.91
Dec 31, 2023 834,644.63
Dec 31, 2022 680,409.65
Dec 31, 2021 568,806.38
API Access

CytoMed Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=GDTC&period=max&api_key=YOUR_API_KEY